RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -56.2 Million EUR | -169.5% |
| 2022 | 80.86 Million EUR | 141.77% |
| 2021 | 33.44 Million EUR | -51.98% |
| 2020 | 69.64 Million EUR | 56.49% |
| 2019 | 44.5 Million EUR | 266.17% |
| 2018 | -26.78 Million EUR | 77.41% |
| 2017 | -118.55 Million EUR | -77.17% |
| 2016 | -66.91 Million EUR | -454.42% |
| 2015 | 18.88 Million EUR | 103.52% |
| 2014 | -536.09 Million EUR | -168.56% |
| 2013 | 781.94 Million EUR | -2.45% |
| 2012 | 801.57 Million EUR | 267.86% |
| 2011 | -477.53 Million EUR | -14.86% |
| 2010 | -415.74 Million EUR | 6.56% |
| 2009 | -444.92 Million EUR | -169.21% |
| 2008 | 642.86 Million EUR | 478.03% |
| 2007 | -170.05 Million EUR | 3.45% |
| 2006 | -176.13 Million EUR | 30.75% |
| 2005 | -254.34 Million EUR | -271.33% |
| 2004 | -68.49 Million EUR | -187.87% |
| 2003 | 77.94 Million EUR | -39.99% |
| 2002 | 129.88 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -82.15 Million EUR | -46.17% |
| 2024 Q2 | -100.44 Million EUR | -22.26% |
| 2023 Q1 | 62.15 Million EUR | -23.14% |
| 2023 Q2 | -68.06 Million EUR | -209.51% |
| 2023 FY | -56.2 Million EUR | -169.5% |
| 2023 Q3 | -3.29 Million EUR | 95.16% |
| 2023 Q4 | -56.2 Million EUR | -1605.25% |
| 2022 Q2 | 57.92 Million EUR | 145.16% |
| 2022 FY | 80.86 Million EUR | 141.77% |
| 2022 Q3 | 74.33 Million EUR | 28.31% |
| 2022 Q4 | 80.86 Million EUR | 8.79% |
| 2022 Q1 | -128.26 Million EUR | -483.48% |
| 2021 Q4 | 33.44 Million EUR | 124.06% |
| 2021 Q1 | -120.47 Million EUR | -272.97% |
| 2021 FY | 33.44 Million EUR | -51.98% |
| 2021 Q3 | -139.04 Million EUR | 18.59% |
| 2021 Q2 | -170.8 Million EUR | -41.78% |
| 2020 FY | 69.64 Million EUR | 56.49% |
| 2020 Q1 | 34.39 Million EUR | -22.71% |
| 2020 Q2 | 37.95 Million EUR | 10.33% |
| 2020 Q3 | -104.18 Million EUR | -374.53% |
| 2020 Q4 | 69.64 Million EUR | 166.85% |
| 2019 Q2 | 5.72 Million EUR | -77.9% |
| 2019 FY | 44.5 Million EUR | 266.17% |
| 2019 Q1 | 25.92 Million EUR | 196.79% |
| 2019 Q4 | 44.5 Million EUR | 143.47% |
| 2019 Q3 | -102.38 Million EUR | -1887.17% |
| 2018 Q4 | -26.78 Million EUR | 63.14% |
| 2018 Q1 | -104.28 Million EUR | 12.03% |
| 2018 FY | -26.78 Million EUR | 77.41% |
| 2018 Q2 | -103.16 Million EUR | 1.07% |
| 2018 Q3 | -72.65 Million EUR | 29.57% |
| 2017 Q3 | -126.87 Million EUR | -28.76% |
| 2017 FY | -118.55 Million EUR | -77.17% |
| 2017 Q4 | -118.55 Million EUR | 6.56% |
| 2017 Q2 | -98.53 Million EUR | -16.14% |
| 2017 Q1 | -84.84 Million EUR | -26.79% |
| 2016 Q3 | -70.73 Million EUR | -56.86% |
| 2016 Q2 | -45.09 Million EUR | 5.8% |
| 2016 Q4 | -66.91 Million EUR | 5.41% |
| 2016 FY | -66.91 Million EUR | -454.42% |
| 2016 Q1 | -47.87 Million EUR | -353.57% |
| 2015 FY | 18.88 Million EUR | 103.52% |
| 2015 Q4 | 18.88 Million EUR | 105.88% |
| 2015 Q3 | -321.13 Million EUR | -112.52% |
| 2015 Q2 | -151.1 Million EUR | 20.66% |
| 2015 Q1 | -190.45 Million EUR | 64.47% |
| 2014 FY | -536.09 Million EUR | -168.56% |
| 2014 Q2 | -2.11 Billion EUR | 1.97% |
| 2014 Q1 | -2.16 Billion EUR | -376.37% |
| 2014 Q3 | -2.15 Billion EUR | -1.7% |
| 2014 Q4 | -536.09 Million EUR | 75.12% |
| 2013 Q1 | 800.8 Million EUR | -0.1% |
| 2013 FY | 781.94 Million EUR | -2.45% |
| 2013 Q4 | 781.94 Million EUR | 3.59% |
| 2013 Q3 | 754.85 Million EUR | -5.67% |
| 2013 Q2 | 800.26 Million EUR | -0.07% |
| 2012 Q1 | -360.73 Million EUR | 24.46% |
| 2012 Q2 | -358.51 Million EUR | 0.62% |
| 2012 Q3 | -187.43 Million EUR | 47.72% |
| 2012 Q4 | 801.57 Million EUR | 527.67% |
| 2012 FY | 801.57 Million EUR | 267.86% |
| 2011 Q1 | -395.17 Million EUR | 4.95% |
| 2011 FY | -477.53 Million EUR | -14.86% |
| 2011 Q2 | -360.26 Million EUR | 8.83% |
| 2011 Q3 | -369.7 Million EUR | -2.62% |
| 2011 Q4 | -477.53 Million EUR | -29.17% |
| 2010 Q1 | -470.11 Million EUR | -5.66% |
| 2010 FY | -415.74 Million EUR | 6.56% |
| 2010 Q4 | -415.74 Million EUR | -2.96% |
| 2010 Q3 | -403.8 Million EUR | 0.8% |
| 2010 Q2 | -407.05 Million EUR | 13.41% |
| 2009 FY | -444.92 Million EUR | -169.21% |
| 2009 Q4 | -444.92 Million EUR | 0.0% |
| 2008 FY | 642.86 Million EUR | 478.03% |
| 2007 FY | -170.05 Million EUR | 3.45% |
| 2006 FY | -176.13 Million EUR | 30.75% |
| 2005 FY | -254.34 Million EUR | -271.33% |
| 2004 FY | -68.49 Million EUR | -187.87% |
| 2003 FY | 77.94 Million EUR | -39.99% |
| 2002 FY | 129.88 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | -11867.983% |
| Arem Pacific Corporation | 181.02 Thousand USD | 31148.541% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | -28043.026% |
| BioCorRx Inc. | 5.56 Million USD | 1109.156% |
| Bionik Laboratories Corp. | 1.98 Million USD | 2931.592% |
| Banyan Corp. | 3.6 Million USD | 1658.405% |
| Clearday, Inc. | 44.86 Million USD | 225.267% |
| Dental Patient Care America, Inc. | -1.99 Million USD | -2714.479% |
| Quantum Medical Transport, Inc. | 1065.27 USD | 5276227.179% |
| Empower Clinics Inc. | 2.29 Million USD | 2544.921% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | 341.952% |
| Selectis Health, Inc. | 35.76 Million USD | 257.164% |
| Ethema Health Corporation | 14.51 Million USD | 487.233% |
| HealthLynked Corp. | 1.72 Million USD | 3355.392% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | 507.479% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | 6263.958% |
| Comjoyful International Company | -28.32 Thousand USD | -198300.932% |
| Medical Facilities Corporation | 92.22 Million USD | 160.945% |
| MedSmart Group Inc. | 659.56 Thousand USD | 8621.577% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | 21276.271% |
| Nova Leap Health Corp. | -686.52 Thousand USD | -8086.871% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | 3157.519% |
| PAO Group, Inc. | 639.37 Thousand USD | 8890.616% |
| Primemd Inc. | 4.54 Million USD | 1337.012% |
| Raffles Medical Group Ltd | -194.49 Million USD | 71.102% |
| Ryman Healthcare Limited | 1.51 Billion USD | 103.721% |
| Stem Cell Authority, Ltd. | 15.00 USD | 374700100.0% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | 4621.285% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | 7025.918% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | -14651.969% |
| Veltex Corporation | 2.17 Million USD | 2678.896% |
| World Financial Holding Group | 98.11 Thousand USD | 57385.987% |
| Xcelerate Inc. | 1.18 Million USD | 4852.001% |